Dr. Thomas Powles: ADC combined with immunotherapy promises to reshape the treatment landscape for urothelial cancer
Editor's Note: The landscape of advanced urothelial cancer (UC) treatment is rapidly evolving. Historically dominated by platinum-based chemotherapies, recent years have seen a paradigm shift towards more targeted therapies and…